Dr. Binu T. Kuruvilla completed his medical graduation from Kerala, India before joining clinical practice. He has worked with various multi-speciality hospitals in medicine and oncology department prior to joining Curegarden. With an interest in clinical research and new drug development, he is keenly involved in protocol design, implementation and management of preclinical and human clinical trials, and works as co-investigator in various clinical trials. His area of expertise also pans collaborative research with both national and international universities and partners in oncology, cardiovascular, metabolic, inflammatory and neurodegenerative disorders, and in the management and publication of international peer reviewed journals.
Dr Kuruvilla co-authored a study in which BCM-95 curcumin was shown to be superior to prescription drugs in treating osteoarthritis. Arjuna’s BCM-95®, is currently the world’s largest selling bio- available turmeric extract helping to prevent a wide range of inflammatory diseases like arthritis, metabolic diseases, cardiovascular disease and cancer. The highly advanced R&D unit at Arjuna is a complete research facility for phytochemistry, pharmacokinetics, formulation and development, pre-clinical and clinical studies. Arjuna’s state of the art laboratory has been approved for in-house research by the Ministry of Science & Technology, Government of India.
Following 30 years in private practice as a Nutritional Biochemist, Christine is currently engaged in doctoral research at the University of Queensland, investigating bioactive nutrigenomic phytochemicals with significant clinical potential. She is an accomplished writer and an engaging speaker whose evidence-supported presentations may challenge accepted but often-outdated paradigms.
Christine’s forte lies in taking complex biochemical concepts and translating their essence into concepts relevant to the needs of practising clinicians. She is a regular presenter at medical and nutrition conferences where her knowledge of and enthusiasm for the roles of Nutritional Medicine and Nutrigenomics in human health are very evident.
She is the author of “Switched On – Harnessing the Power of Nutrigenomics to Optimise Health”. Her peer-reviewed publications include the Special Article published in 2013 in Nutrition Reviews: “Sulforaphane: Translational Medicine from Lab Bench to Clinic”.
Dr. Kohei Homma received his PhD in 2003 from the Graduate School of Agricultural and Life Sciences, the University of Tokyo, JAPAN, for a research of a protein crystallization in microgravrly environment on a NASA space shuttle.
Immediately after the PhD program, he started working in the United States as an academic researcher. His last position in the US academia was an Instructor at the Department of Pathology and Microbiology, University of Nebraska Medical Center.
In 2010, Dr. Homma Joined Amino Up, one of Japan’s leading biotechnology company. The company focuses in the field of nutrition, complementary and integrative medicine or, more broadly, integrative health, which is important approach for disease prevention and global health promotion.